FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2802197918> ?p ?o ?g. }

• W2802197918 endingPage "1388" @default.
• W2802197918 startingPage "1377" @default.
• W2802197918 abstract "Adherence to COPD treatment in Turkey and Saudi Arabia: results of the ADCARE study Nurdan Kokturk,1 Mehmet Polatli,2 I Kivilcim Oguzulgen,1 Sarfraz Saleemi,3 Mohammed Al Ghobain,4 Javed Khan,5 Adam Doble,6 Luqman Tariq,7 Fayaz Aziz,7 Abdelkader El Hasnaoui7 1Department of Pulmonary Medicine, School of Medicine, Gazi University, Besevler, Turkey; 2Department of Pulmonary Medicine, School of Medicine, Adnan Menderes University, Aydin, Turkey; 3Section of Pulmonary Medicine, Department of Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia; 4Department of Medicine, College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia; 5Department of Medicine, King Fahd Armed Forces Hospital, Jeddah, Saudi Arabia; 6Foxymed, Paris, France; 7GlaxoSmithKline, Dubai, UAE Background: COPD affects millions of people worldwide. Poor treatment adherence contributes to increased symptom severity, morbidity and mortality. This study was designed to investigate adherence to COPD treatment in Turkey and Saudi Arabia. Methods: An observational, cross-sectional study in adult COPD patients in Turkey and Saudi Arabia. Through physician-led interviews, data were collected on sociodemographics and disease history, including the impact of COPD on health status using the COPD Assessment Test (CAT); quality of life, using the EuroQol Five-Dimension questionnaire (EQ-5D); and anxiety and depression using the Hospital Anxiety and Depression Scale (HADS). Treatment adherence was measured using the 8-item Morisky Medication Adherence Scale (MMAS-8). Multivariate logistic regression analysis examined the predictors of non-adherence and the impact of adherence on symptom severity. Results: Four hundred and five COPD patients participated: 199 in Turkey and 206 in Saudi Arabia. Overall, 49.2% reported low adherence (MMAS-8 <6). Of those, 74.7% reported high disease impact (CAT >15) compared to 58.4% reporting medium/high adherence (p=0.0008). Patients with low adherence reported a lower mean 3-level EQ-5D utility value (0.54±0.35) compared to those with medium/high adherence (0.64±0.30; p<0.0001). Depression with HADS score 8–10 or >10 was associated with lower adherence (OR 2.50 [95% CI: 1.43–4.39] and 2.43 [95% CI: 1.39–4.25], respectively; p=0.0008). Being a high school/college graduate was associated with better adherence compared with no high school (OR 0.57 [95% CI: 0.33–0.98] and 0.38 [95% CI: 0.15–1.00], respectively; p=0.0310). After adjusting for age, gender, and country, a significant association between treatment adherence (MMAS-8 score ≥6) and lower disease impact (CAT ≤15) was observed (OR 0.56 [95% CI: 0.33–0.95]; p=0.0314). Conclusion: Adherence to COPD treatment is poor in Turkey and Saudi Arabia. Non-adherence to treatment is associated with higher disease impact and reduced quality of life. Depression, age, and level of education were independent determinants of adherence. Keywords: COPD, non-adherence, 8-item Morisky Medication Adherence Scale, MMAS-8, EuroQol Five-Dimension questionnaire, EQ-5D, COPD Assessment Test, CAT, Turkey, Saudi Arabia" @default.
• W2802197918 created "2018-05-17" @default.
• W2802197918 creator A5003927892 @default.
• W2802197918 creator A5011828746 @default.
• W2802197918 creator A5023428701 @default.
• W2802197918 creator A5025428808 @default.
• W2802197918 creator A5037920803 @default.
• W2802197918 creator A5039665005 @default.
• W2802197918 creator A5058717789 @default.
• W2802197918 creator A5060385693 @default.
• W2802197918 creator A5063091333 @default.
• W2802197918 creator A5075293839 @default.
• W2802197918 date "2018-04-01" @default.
• W2802197918 modified "2023-10-15" @default.
• W2802197918 title "Adherence to COPD treatment in Turkey and Saudi Arabia: results of the ADCARE study" @default.
• W2802197918 cites W1480729244 @default.
• W2802197918 cites W1558629758 @default.
• W2802197918 cites W1574668642 @default.
• W2802197918 cites W1616275401 @default.
• W2802197918 cites W1845447069 @default.
• W2802197918 cites W1963695116 @default.
• W2802197918 cites W1966242613 @default.
• W2802197918 cites W1967200344 @default.
• W2802197918 cites W1968551787 @default.
• W2802197918 cites W1975240712 @default.
• W2802197918 cites W1992927517 @default.
• W2802197918 cites W1993643657 @default.
• W2802197918 cites W1997631109 @default.
• W2802197918 cites W1999957902 @default.
• W2802197918 cites W2010793777 @default.
• W2802197918 cites W2026922655 @default.
• W2802197918 cites W2034242620 @default.
• W2802197918 cites W2048251717 @default.
• W2802197918 cites W2054931962 @default.
• W2802197918 cites W2058049114 @default.
• W2802197918 cites W2067470530 @default.
• W2802197918 cites W2071671062 @default.
• W2802197918 cites W2071686284 @default.
• W2802197918 cites W2084752662 @default.
• W2802197918 cites W2095666112 @default.
• W2802197918 cites W2099676542 @default.
• W2802197918 cites W2105433837 @default.
• W2802197918 cites W2105773138 @default.
• W2802197918 cites W2107829061 @default.
• W2802197918 cites W2108145404 @default.
• W2802197918 cites W2123277906 @default.
• W2802197918 cites W2124386100 @default.
• W2802197918 cites W2128643205 @default.
• W2802197918 cites W2132683688 @default.
• W2802197918 cites W2133746099 @default.
• W2802197918 cites W2136814988 @default.
• W2802197918 cites W2137238931 @default.
• W2802197918 cites W2144141229 @default.
• W2802197918 cites W2157968241 @default.
• W2802197918 cites W2159480781 @default.
• W2802197918 cites W2160604800 @default.
• W2802197918 cites W2162130500 @default.
• W2802197918 cites W2164011121 @default.
• W2802197918 cites W2166281097 @default.
• W2802197918 cites W2182373258 @default.
• W2802197918 cites W2194126186 @default.
• W2802197918 cites W2270009591 @default.
• W2802197918 cites W2320830868 @default.
• W2802197918 cites W2344251667 @default.
• W2802197918 cites W2461444720 @default.
• W2802197918 cites W2473786944 @default.
• W2802197918 cites W2482401905 @default.
• W2802197918 cites W2528385426 @default.
• W2802197918 cites W2604610932 @default.
• W2802197918 cites W2614986146 @default.
• W2802197918 cites W611638444 @default.
• W2802197918 doi "https://doi.org/10.2147/copd.s150411" @default.
• W2802197918 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5927343" @default.
• W2802197918 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29731625" @default.
• W2802197918 hasPublicationYear "2018" @default.
• W2802197918 type Work @default.
• W2802197918 sameAs 2802197918 @default.
• W2802197918 citedByCount "27" @default.
• W2802197918 countsByYear W28021979182019 @default.
• W2802197918 countsByYear W28021979182020 @default.
• W2802197918 countsByYear W28021979182021 @default.
• W2802197918 countsByYear W28021979182022 @default.
• W2802197918 countsByYear W28021979182023 @default.
• W2802197918 crossrefType "journal-article" @default.
• W2802197918 hasAuthorship W2802197918A5003927892 @default.
• W2802197918 hasAuthorship W2802197918A5011828746 @default.
• W2802197918 hasAuthorship W2802197918A5023428701 @default.
• W2802197918 hasAuthorship W2802197918A5025428808 @default.
• W2802197918 hasAuthorship W2802197918A5037920803 @default.
• W2802197918 hasAuthorship W2802197918A5039665005 @default.
• W2802197918 hasAuthorship W2802197918A5058717789 @default.
• W2802197918 hasAuthorship W2802197918A5060385693 @default.
• W2802197918 hasAuthorship W2802197918A5063091333 @default.
• W2802197918 hasAuthorship W2802197918A5075293839 @default.
• W2802197918 hasBestOaLocation W28021979181 @default.
• W2802197918 hasConcept C118552586 @default.
• W2802197918 hasConcept C126322002 @default.
• W2802197918 hasConcept C139719470 @default.

• next